Latest Breaking News On - Corporate communications investors - Page 6 : comparemela.com

Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023

Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSteve dabkowskiPaul hughesCorporate communications investorsPharmaceuticals coMarrow transplant researchResearch developmentMesoblast limited nasdaqAustralian securities exchangeDrug administrationJournal of the american college cardiologyBiologics license applicationPrescription drug user fee actPre license inspectionFood drug

Appendix 4C Quarterly Activity Report

Appendix 4C Quarterly Activity Report
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPaul hughesLonza bioscienceSteve dabkowskiAustralian securities exchangePharmaceuticals coCorporate communications investorsMarrow transplant researchDrug administrationMesoblast limited nasdaqJournal of the american college cardiologyWall streetBiologics license applicationComplete response letterPrescription drug user fee act

Mesoblast Completes Private Placement

Mesoblast Completes Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSteve dabkowskiLonza biosciencesSilviu itescuPaul hughesUs food drug administrationAustralian securities exchangeCorporate communications investorsMesoblast limited nasdaqDrug administrationBiologics license applicationExecutive dr silviu itescuMesoblast limitedLooking statementsthisPrivate securities litigation reform act

FDA Schedules Pre-License Inspection of Remestemcel-L

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date.

United statesLonza bioscienceSilviu itescuSteve dabkowskiPaul hughesMarrow transplant researchDrug administrationInternational bloodAustralian securities exchangeMarrow transplantation groupOncologic drugs advisory committeeCorporate communications investorsWorldwide network for bloodMesoblast limitedMount sinai acute gvhd international consortiumBiologics license application

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLonza bioscienceSilviu itescuSteve dabkowskiPaul hughesMarrow transplant researchDrug administrationInternational bloodAustralian securities exchangeMarrow transplantation groupOncologic drugs advisory committeeCorporate communications investorsWorldwide network for bloodMesoblast limitedMount sinai acute gvhd international consortiumLicense application